Author Archives: Warren Woessner

Cutting Through the Patent Thicket – The Little Bill that Couldn’t

Posted on June 18, 2019 by Warren Woessner

A bill was recently proposed to “reduce the improper issuance of patents that improperly extend the term of exclusivity afforded a new drug or biological product.” The bill would amend the patent statutes (s. 253 or title 35) for add … Continue reading →

Posted in Drug Patent Term | Tagged , , , , , | Leave a comment

Senate Subcommittee Hearing of Patent Eligibility Wrap Up – Now What?

Posted on June 13, 2019 by Warren Woessner

In my first post on the Subcommittee Hearings held last week, I noted the absence of many witnesses from the life science industry, as opposed to groups such as IPO, AIPLA, BIO, ACLU and PhMA. The third and final panel, … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

Senate Subcommittee on IP Feels our PAIN

Posted on June 6, 2019 by Warren Woessner

In lengthy hearings conducted by the Senate Subcommittee on Intellectual Property (of the Committee on the Judiciary) on June 4th and 5th (Parts I and II; Part III will be held on June 11th), the Subcommittee, chaired by Senators Tillis … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Chisum Patent Academy – Seattle Seminar, August 2019

Posted on May 29, 2019 by Warren Woessner

Guest Post from the Chisum Patent Academy. Join us this Summer in beautiful Seattle, Washington for Critical Patent Law Updates! Registration is now open for our remaining advanced patent law seminar of 2019.  August 8 (Thurs) – August 9 (Fri) … Continue reading →

Posted in Conferences and Classes | Leave a comment